Los Angeles Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Los Angeles Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-240,008	Closed	-$826K	–	1694
2021 Q1	$826K	Sell	240,008 -2,420	-1%	-$7.53K	﹤0.01%	987
2020 Q4	$611K	Sell	242,428 -10,700	-4%	-$23.3K	﹤0.01%	1125
2020 Q3	$534K	Buy	253,128 +11,653	+5%	+$27.7K	﹤0.01%	1054
2020 Q2	$541K	Buy	+241,475	New	+$621K	﹤0.01%	1087
2019 Q4	–	Sell	-10,084	Closed	-$36K	–	1364
2019 Q3	$36K	Hold	10,084	–	–	﹤0.01%	1255
2019 Q2	$34K	Sell	10,084 -75,439	-88%	-$266K	﹤0.01%	1328
2019 Q1	$233K	Sell	85,523 -20,860	-20%	-$68.3K	﹤0.01%	1272
2018 Q4	$296K	Sell	106,383 -1,100	-1%	-$3.6K	﹤0.01%	1105
2018 Q3	$443K	Buy	107,483 +30,370	+39%	+$138K	﹤0.01%	1130
2018 Q2	$400K	Buy	+77,113	New	+$470K	﹤0.01%	1197

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Los Angeles Capital Management's ENZ Position: Q2 2021 in Review

Los Angeles Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 240,008 shares — an estimated $826K sold.

Los Angeles Capital Management first reported a position in ENZ in Q2 2018 and held it in 10 quarters. The position peaked at $826K in Q1 2021. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.

Los Angeles Capital Management reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
Los Angeles Capital Management sold 240,008 Enzo Biochem, Inc. shares in Q2 2021, an estimated $826K.
Los Angeles Capital Management first reported a position in Enzo Biochem, Inc. in Q2 2018 and held it in 10 quarters.
Los Angeles Capital Management's Enzo Biochem, Inc. position peaked at $826K in Q1 2021.
72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.

Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.